Technology » Background
MTR104 is the designation for the drug substance S-ethylisothiouronium diethylphosphate serving as the Active Pharmaceutical Ingredient (API) of Meditor's drug product coded as MTR-105 (injectable i.v. form) and MTR-106 (oral dosage form).
![]() |
Conventional Treatment with sympathomimetics vs. MTR The older generation of sympathomimetic drugs result in “overshoot” from hypotension to excessive hypertension, and in most cases leads to secondary hypotension episodes. In contrast, MTR’s immediate-acting, moderate-lasting “ceiling effect”, keeps blood pressure within healthy levels. |
